Cytokine profile in Behçet uveitis

Bratislava Medical Journal

Volumn 109, Issue 12, 2008, Pages 551-554

  Nalbant, Selim ^a   Sahan, Burak ^a   Durna, Murat ^a   Ersanli, Dilaver ^a   Kaplan, Mustafa ^a   Karabudak, Ozlem ^a   Unal, Melih ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Beh et's disease; Cytokines; Uveitis

Indexed keywords

CYTOKINE; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ADULT; ARTICLE; BEHCET DISEASE; BLOOD; FEMALE; HUMAN; MALE; UVEITIS;

ADULT; BEHCET SYNDROME; CYTOKINES; FEMALE; HUMANS; INTERLEUKINS; MALE; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62549105722     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yurdakul S, Hamuryudan V, Yazici H. Behçet syndrome. Curr Opin Rheumatol 2004; 16 (1): 38-42.
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. New Engl J Med 1999; 341 (17): 1284-1291.
3. Jae Kyoun Ahn, Hyeong Gon Yu, Hum Chung, Yeoung Geol Park. Intraocular Cytokine Environment in Active Behçet Uveitis. Amer J Ophthalmol 2006; 142 (3): 429-434.
4. Calder VL, Shaer B, Muhaya M et al. Increased CD4 expression and decreased IL-10 in the anterior chamber in idiopathic uveitis. Invest Ophthalmol Vis Sci 1999; 40 (9): 2019-2024.
5. Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H. Involvement of chemokines and Thl cytokines in the pathogenesis of muco-cutaneous lesions of Behçet's disease. Arthritis Rheum 2004; 50 (7): 2291-2295.
6. Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici. Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. H J Rheumatol 2002; 29(11): 2393-2396.
7. Nussenblatt RB. Uveitis in Behçet's disease. Int Rev Immunol 1997; 14 (1): 67-79.
8. Matsuo T, Itami M, Nakagawa H, Nagayama M. The incidence and pathology of conjunctival ulceration in Behçet's syndrome. Brit J Ophthalmol 2002; 86 (2): 140-143.
9. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335 (8697): 1078-1080.
10. Standardization of Uveitis Nomenclature (SDN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Amer J Ophthalmol 2005; 140: 509-516.
11. Sfikakis PP, Kaklamanis PH, Elezoglou A et al. Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades- Behçet disease. Ann Intern Med 2004; 140 (5): 404-406.
12. Markomichelakis NN, Theodossiadis PG, Pantelia E et al. Infliximab for chronic cystoid mascular edema associated with uveitis. Amer J Ophthalmol 2004; 138: 648-650.
13. Tugal-Tutkun I, Mudun A, Urgancioglu M et al. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behet's disease: an open-label trial. Arthritis Rheum 2005; 52: 2478-2484.
14. Saruhan-Direskeueli G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003; 145: 127-134.
15. Ahn JK, Seo JM, Ye Yu J et al. Down-regulation of IFN-gamma producing CD56 T cells after combined low dose cyclosporine and prednisone treatment in active Behet's uveitis patients. Invest Ophthalmol Vis Sci 2005; 46: 2458-2464.
16. Ahn JK, Chung H, Lee DS, Yu YS, Yu HG. CD8 and CD56 T cells are cytotoxic effectors in patients with active Behçet's uveitis. J Immunol 2005; 175: 6133-6142.
17. Lacomba MS, Martin CM, Chamond RR et al. Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol 2000; 118: 768-772.
18. Ongkosuwito JV, Feron EJ, van Doornik CE et al. Analysis of immunoregulatory cytokines in ocular fluid sample from patients with uveitis. Invest Ophthalmol Vis Sci 1998; 39: 2659-2665.
19. Hill T, Galatowicz G, Akerele T et al. Intracellular T lymphocyte cytokine profiles in the aqueous humor of patients with uveitis and correlation with clinical phenotype. Clin Exp Immunol 2005; 139: 132-137.
20. Yamaoka J, Kabashima K, Kawanishi M, Toda K, Miyachi Y. Cytotoxicity of IFN-gamma and TNF-alpha for vascular endothelial cell is mediated by nitric oxide. Biochem Biophy Res Commun 2002; 291: 780-786.